scispace - formally typeset
Open AccessJournal ArticleDOI

A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China.

Reads0
Chats0
TLDR
Wu et al. as mentioned in this paper reviewed clinical and laboratory features and treatment of cats highly suspected of FIP in Wuhan, China, for history, clinical signs, physical findings, and diagnostic test results.
Abstract
Feline infectious peritonitis (FIP) is a systemic, potentially fatal viral disease. The objectives of this study were to review clinical and laboratory features and treatment of cats highly suspected of FIP in Wuhan, China. The clinical records of 127 cats highly suspected of FIP were reviewed for history, clinical signs, physical findings, and diagnostic test results. Sex, neutering status, breed, age, and month of onset of disease were compared with the characteristics of the clinic population. Age and neutering status were significantly correlated with FIP-suspicion. Sex, breed and onset month were not associated with FIP. There were many more FIP-suspected cases in cats in young cats or male intact cats. Effusion was observed in 85.8% of the FIP-suspected cats. Increased serum amyloid A (SAA) and lymphopenia were common laboratory abnormalities in the FIP cases. Furthermore, 91.7% of the cats highly suspected of FIP had an albumin/globulin (A/G) ratio < 0.6, while 85.3% had an A/G ratio < 0.5. The mortality rate for FIP-suspected cats was 67%, and six submitted cases were confirmed by FIP-specific immunohistochemistry. Of the 30 cats treated with GS-441524 and/or GC376, 29 were clinically cured. The study highlights the diverse range of clinical manifestations by clinicians in diagnosing this potentially fatal disease. A/G ratio and SAA were of higher diagnostic value. GS-441524 and GC376 were efficient for the treatment of FIP-suspected cats.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Outbreak of feline infectious peritonitis (FIP) in shelter-housed cats: molecular analysis of the feline coronavirus S1/S2 cleavage site consistent with a ‘circulating virulent–avirulent theory’ of FIP pathogenesis

TL;DR: This case series provides interesting data on point mutations associated with the development of FIP and provides support for a ‘circulating virulent–avirulent theory’ of Fip pathogenesis in a small shelter outbreak.
Journal ArticleDOI

2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines

TL;DR: The 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines as discussed by the authors were developed to provide veterinarians with essential information to aid their ability to recognize cats presenting with FIP.
Journal ArticleDOI

Feline Coronavirus Antivirals: A Review.

TL;DR: In this article, a review of antiviral therapy against FCoV both in vitro and in vivo, with the description of their mechanisms of action when known, highlights the molecules which could have a broader effect on different coronaviruses.
Journal ArticleDOI

Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge

TL;DR: In this article, the authors investigated the clinical signs, duration, and amount of FCV shedding, RNAemia, haematological changes and acute phase protein reaction in SPF cats after subcutaneous modified-live single strain FCV vaccination or placebo injection and two subsequent oronasal heterologous FCV challenge infections with two different field strains.
References
More filters
Journal ArticleDOI

Nucleoside analogues for the treatment of coronavirus infections

TL;DR: This review will discuss progress made in the development of antiviral nucleoside and nucleotide analogues targeting viral RNA synthesis as effective therapeutics against CoV infections and propose promising strategies for combination therapy.
Journal ArticleDOI

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis.

TL;DR: GS-441524 was shown to be a safe and effective treatment for FIP and the optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks.
Journal ArticleDOI

An update on feline infectious peritonitis: Diagnostics and therapeutics

TL;DR: There is still no effective treatment for FIP, although there are both claims that such therapies exist and glimmers of hope coming from new therapies that are under research.
Journal Article

Serologic studies of naturally occurring feline infectious peritonitis.

TL;DR: Serum antibodies to the feline infectious peritonitis (FIP) virus were measured in cats, using an indirect fluorescent antibody procedure, finding that although the infection rate is high among cats, relatively few of the cats infected with the FIP virus ever develop clinically apparent FIP.
Journal ArticleDOI

The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies

TL;DR: In an experimental FIPV infection of cats, GS-441524 treatment caused a rapid reversal of disease signs and return to normality with as little as two weeks of treatment in 10/10 cats and with no apparent toxicity.
Related Papers (5)